Literature DB >> 11897163

Intrathecal alpha2 adrenoceptor agonist clonidine inhibits mechanical transmission in mouse spinal cord via activation of muscarinic M1 receptors.

Kenji Honda1, Kohei Koga, Tomoko Moriyama, Masako Koguchi, Yukio Takano, Hiro-o Kamiya.   

Abstract

We examined the role of the spinal muscarinic receptor subtype in the anti-nociceptive effect of intrathecal (i.t.) alpha2 adrenoceptor agonist clonidine in mice. I.t. injection of the muscarinic receptor antagonist atropine completely inhibited i.t. clonidine-induced increase in the mechanical threshold, but did not affect the increase in tail-flick latency induced by i.t. clonidine. The clonidine-induced increase in mechanical threshold was inhibited by i.t. injection of the M1 receptor antagonist pirenzepine in a dose-dependent manner, and by the M3 receptor antagonist 4-DAMP, but not by the M2 receptor antagonist methoctramine. The potency of pirenzepine was greater than that of 4-DAMP. These results suggest that the clonidine-induced increase in mechanical threshold is mediated via the activation of M1 receptors in the spinal cord.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11897163     DOI: 10.1016/s0304-3940(02)00073-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  Noradrenergic inhibition of spinal hyperexcitation elicited by cutaneous cold stimuli in rats with oxaliplatin-induced allodynia: electrophysiological and behavioral assessments.

Authors:  Seunghwan Choi; Akihiro Yamada; Woojin Kim; Sun Kwang Kim; Hidemasa Furue
Journal:  J Physiol Sci       Date:  2016-11-28       Impact factor: 2.781

2.  Antagonism by haloperidol and its metabolites of mechanical hypersensitivity induced by intraplantar capsaicin in mice: role of sigma-1 receptors.

Authors:  José M Entrena; Enrique J Cobos; Francisco R Nieto; Cruz M Cendán; José M Baeyens; Esperanza Del Pozo
Journal:  Psychopharmacology (Berl)       Date:  2009-03-27       Impact factor: 4.530

3.  Spinal cholinergic mechanism of the relieving effects of electroacupuncture on cold and warm allodynia in a rat model of neuropathic pain.

Authors:  Jung Hyuk Park; Sun Kwang Kim; Ha Neul Kim; Boram Sun; Sungtae Koo; Sun Mi Choi; Hyunsu Bae; Byung-Il Min
Journal:  J Physiol Sci       Date:  2009-04-03       Impact factor: 2.781

4.  Spinal muscarinic receptors are activated during low or high frequency TENS-induced antihyperalgesia in rats.

Authors:  R Radhakrishnan; K A Sluka
Journal:  Neuropharmacology       Date:  2003-12       Impact factor: 5.250

5.  Phenotypes of pain behavior in phospholipase C-related but catalytically inactive protein type 1 knockout mice.

Authors:  Keisuke Migita; Masahiko Tomiyama; Junko Yamada; Masashi Fukuzawa; Takashi Kanematsu; Masato Hirata; Shinya Ueno
Journal:  Mol Pain       Date:  2011-10-18       Impact factor: 3.395

6.  Activations of muscarinic M1 receptors in the anterior cingulate cortex contribute to the antinociceptive effect via GABAergic transmission.

Authors:  Kohei Koga; Yu Matsuzaki; Kenji Honda; Fumihiro Eto; Tomonori Furukawa; Keisuke Migita; Keiichi Irie; Kenichi Mishima; Shinya Ueno
Journal:  Mol Pain       Date:  2017-01       Impact factor: 3.395

7.  Systematic Administration of B Vitamins Alleviates Diabetic Pain and Inhibits Associated Expression of P2X3 and TRPV1 in Dorsal Root Ganglion Neurons and Proinflammatory Cytokines in Spinal Cord in Rats.

Authors:  Duan-Duan He; Yu Gao; Shan Wang; Zhong Xie; Xue-Jun Song
Journal:  Pain Res Manag       Date:  2020-02-10       Impact factor: 3.037

8.  CCL-1 in the spinal cord contributes to neuropathic pain induced by nerve injury.

Authors:  N Akimoto; K Honda; D Uta; K Beppu; Y Ushijima; Y Matsuzaki; S Nakashima; M A Kido; K Imoto; Y Takano; M Noda
Journal:  Cell Death Dis       Date:  2013-06-20       Impact factor: 8.469

9.  Mechanisms of electroacupuncture-induced analgesia on neuropathic pain in animal model.

Authors:  Woojin Kim; Sun Kwang Kim; Byung-Il Min
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-31       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.